About Saranas
Saranas is a company based in Houston (United States) founded in 2011.. Saranas has raised $29.46 million across 9 funding rounds from investors including Baird Capital, S3 Ventures and Houston Technology Center. Saranas operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Aziyo Biologics, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.46 M (USD)
in 9 rounds
-
Latest Funding Round
$15.48 M (USD), Series B
Jul 19, 2021
-
Investors
Baird Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Saranas
Saranas has successfully raised a total of $29.46M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $15.48 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $15.5M
-
First Round
First Round
(20 Apr 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series B - Saranas | Valuation | Baird Capital | |
| May, 2020 | Amount | Debt – Conventional - Saranas | Valuation |
investors |
|
| May, 2018 | Amount | Series B - Saranas | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Saranas
Saranas has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Baird Capital, S3 Ventures and Houston Technology Center. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided to Texas-based startups.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Saranas
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Saranas
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Saranas Comparisons
Competitors of Saranas
Saranas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Cardival Medical and Aziyo Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
|
| domain | founded_year | HQ Location |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| domain | founded_year | HQ Location |
A device for vascular access management is developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Saranas
Frequently Asked Questions about Saranas
When was Saranas founded?
Saranas was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Saranas located?
Saranas is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Is Saranas a funded company?
Saranas is a funded company, having raised a total of $29.46M across 9 funding rounds to date. The company's 1st funding round was a Series B of $2.8M, raised on Apr 20, 2012.
What does Saranas do?
Saranas was founded in 2011 and is headquartered in Houston, United States. Operations focus on the medical device sector, where a tool called Early Bird is created to identify internal bleeding risks in catheterization procedures. The device incorporates a cardiac sheath integrated with electrodes that assess electrical resistance variations across blood vessels, supporting safer vascular interventions.
Who are the top competitors of Saranas?
Saranas's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
Who are Saranas's investors?
Saranas has 3 investors. Key investors include Baird Capital, S3 Ventures, and Houston Technology Center.